Chao-Hung Hung

发表

Clinical Significance of Hepatitis B Virus (HBV) Genotypes and Precore and Core Promoter Mutations Affecting HBV e Antigen Expression in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Journal of Clinical Microbiology.

Hepatoma‐derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors

Sheng-Nan Lu, Chien-Hung Chen, M. Tai, 2007, International journal of cancer.

FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis

Sheng-Nan Lu, Chao-Hung Hung, Hock-Liew Eng, 2009, Journal of Gastroenterology.

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Medicine.

Revisiting the accuracy of splenomegaly by sonography in patients with chronic hepatitis B

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Advances in Digestive Medicine.

Low accuracy of the national reporting system of acute hepatitis C infection in Taiwan, 1995–2004

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2010, Journal of gastroenterology and hepatology.

Hepatitis C virus genotypes: clinical relevance and therapeutic implications.

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2008, Chang Gung medical journal.

Viral Etiology of Hepatocellular Carcinoma and HCV Genotypes in Taiwan

Sheng-Nan Lu, Chao-Long Chen, C. Changchien, 2005, Intervirology.

Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, The Journal of antimicrobial chemotherapy.

Is Hepatitis C Virus Core Antigen an Adequate Marker for Community Screening?

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2012, Journal of Clinical Microbiology.

Comparison of prevalence for paraumbilical vein patency in patients with viral and alcoholic liver cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002, American Journal of Gastroenterology.

Comparison of prevalence for paraumbilical vein patency in patients with viral and alcoholic liver cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002 .

Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir therapy.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comparison of HBsAg changes between HBeAg-negative patients who discontinued or maintained entecavir therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Hepatology International.

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Alimentary pharmacology & therapeutics.

Antiviral effect of entecavir in nucleos(t)ide analogue‐naïve and nucleos(t)ide analogue‐experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2014, Journal of viral hepatitis.

High Risk of Hepatitis B Virus Reactivation in Nucleos(t)ide Analogue-Induced Hepatitis B e Antigen Seroconverters Older Than 40 Years

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2014, Digestive Diseases and Sciences.

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, The Journal of antimicrobial chemotherapy.

A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, Hepatology International.

Treatment Response and Evolution of HBV Resistance during Lamivudine plus Adefovir or Entecavir Therapy in Patients with Adefovir-Resistant Mutants

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2012, Antiviral therapy.

Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon‐alfa in hepatitis‐B‐e‐antigen‐positive patients

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Journal of gastroenterology and hepatology.

A study on sequence variations in pre‐S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non‐B, non‐C hepatocellular carcinoma patients in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2009, International journal of cancer.

The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2009, Journal of hepatology.

Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008, The Journal of infectious diseases.

Combined Mutations in PreS / Surface and Core Promoter / Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma : A Case-Control Study

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008 .

Optimal treatment increased survival of hepatocellular carcinoma patients detected with community‐based screening

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Journal of gastroenterology and hepatology.

Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2009, Vaccine.

Correlation Between Fatty Liver and Lipidemia in Taiwanese

C. Changchien, T. Tsai, Jing-Houng Wang, 2003 .

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, International journal of cancer.

Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Prognostic factors of radiofrequency ablation therapy for liver metastases from colorectal cancer

Sheng-Nan Lu, Yueh-Wei Liu, Chao-Hung Hung, 2019, Advances in Digestive Medicine.

Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Association of inflammatory and anti‐inflammatory cytokines with insulin resistance in chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience

Sheng-Nan Lu, I. Sheen, R. Chien, 2019, Journal of viral hepatitis.

Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.

Sheng-Nan Lu, Chi-Chih Wang, Jing-Houng Wang, 2012, Journal of hepatology.

Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection

Chien-Hung Chen, Chao-Hung Hung, T. Hu, 2019, BMC Cancer.

Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection

C.-H. Chen, Chi-Chih Wang, R. Chien, 2021, Liver Cancer.

The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.

Sheng-Nan Lu, Chien-Hung Chen, Chao-Min Huang, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, The Kaohsiung journal of medical sciences.

Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, R. Chien, 2020, Alimentary pharmacology & therapeutics.

Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2014, OncoTargets and therapy.

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

Mei-Hsuan Lee, J. Kao, Chun-Jen Liu, 2021, Infectious Diseases and Therapy.

A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse.

Sheng-Nan Lu, Yi‐Hsiang Huang, C. Yeh, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Role of Viral Genotypes and Hepatitis B Viral Mutants in the Risk of Hepatocellular Carcinoma Associated with Hepatitis B and C Dual Infection

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Intervirology.

Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection

Chi-Chih Wang, Yueh-Wei Liu, Chao-Hung Hung, 2020, Scientific Reports.

A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir

Chien-Hung Chen, S. Chiu, Jing-Houng Wang, 2021, Hepatology International.

Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation

Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang, 2018, Scientific Reports.

A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Medicine.

Relationship Between Flash Echo Gray Scale Imaging Features and Pathologic Findings in Hepatic Adenoma

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, European journal of radiology.

Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B

Sheng-Nan Lu, Chuan-Pin Lee, Yao-Hsu Yang, 2021, Scientific Reports.

Comparison of Salvage Living Donor Liver Transplantation and Local Regional Therapy for Recurrent Hepatocellular Carcinoma

Sheng-Nan Lu, Chao-Long Chen, Chi-Chih Wang, 2016, World Journal of Surgery.

Diabetes mellitus is associated with gastroesophageal variceal bleeding in cirrhotic patients

C.-H. Chen, S. Chuah, Y. Chiu, 2014, The Kaohsiung journal of medical sciences.

Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis

Sheng-Nan Lu, S. Chuah, Jing-Houng Wang, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Liver stiffness measurement in cirrhotic patient — Implications of disease activity and treatment efficacy

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2012, The Kaohsiung journal of medical sciences.

Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis.

Chao-Hung Hung, Meng-Chih Lin, M. Tsai, 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2004, European journal of gastroenterology & hepatology.

Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus‐related cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, S. Chuah, 2012, Journal of gastroenterology and hepatology.

Improvement of Thrombocytopenia in Hepatitis C-Related Advanced Fibrosis Patients After Sustained Virological Response

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Digestive Diseases and Sciences.

Decreased anti‐hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: A prospective study

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, Journal of gastroenterology and hepatology.

Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in Taiwan.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2007, The American journal of tropical medicine and hygiene.

Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor‐κB in chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008, Liver international : official journal of the International Association for the Study of the Liver.

Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Cancers.

Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008, The Journal of infection.

Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment

Jen-I. Hwang, Chien-Hung Chen, P. Liang, 2018, Liver Cancer.

Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information.

Sheng-Nan Lu, Chien-Hung Chen, Yi‐Hsiang Huang, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting

Sheng-Nan Lu, Chao-Hung Hung, Y. Hsieh, 2022, PloS one.

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals

J. Kao, Chia-Chi Wang, Han‐Chieh Lin, 2022, Viruses.

Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Digestive Diseases and Sciences.

Real‐world experience of elbasvir/grazoprevir in Taiwan: This study was focused on liver and renal adverse effects

Sheng-Nan Lu, Chien-Hung Chen, I. Sheen, 2020, Journal of viral hepatitis.

Liver stiffness measurement at complete virological response in hepatoma prediction for HBV‐related cirrhosis patient with potent antiviral agent

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, The Kaohsiung journal of medical sciences.

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus‐related compensated cirrhosis

Chien-Hung Chen, Chuan‐Mo Lee, Chao-Hung Hung, 2014, Journal of gastroenterology and hepatology.

HBsAg Proﬁles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2010 .

A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Cancers.

Flash‐echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Journal of clinical ultrasound : JCU.

Prevalence and clinical relevance of serum autoantibodies in patients with chronic hepatitis C.

Sheng-Nan Lu, Chien-Hung Chen, C. Chung, 2010, Chang Gung medical journal.

Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.

Sheng-Nan Lu, Chien-Hung Chen, M. Tai, 2007, Oncology reports.

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection

Chi-Chih Wang, Chao-Hung Hung, Chih-Che Lin, 2021, Journal of personalized medicine.

Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan

Sheng-Nan Lu, Chao-Hung Hung, Y. Hsieh, 2021, Scientific Reports.

High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy.

Sheng-Nan Lu, Chao-Hung Hung, Y. Hsieh, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002, Journal of gastroenterology and hepatology.

Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis

Sheng-Nan Lu, Chien-Hung Chen, I. Sheen, 2019, Scientific Reports.

Hepatic Interferon Receptor Mrna Expression: Clinical Relevance and Its Relationship with Effectiveness of Interferon plus Ribavirin Therapy in Patients with Genotype 1B Hepatitis C Virus Infection

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2006, Antiviral therapy.

803 Lee.qxp

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2006 .

Low-dose nivolumab in advanced hepatocellular carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2022, BMC Cancer.

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2007, Gastroenterology.

P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection

Sheng-Nan Lu, Chien-Hung Chen, Chao-Long Chen, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2017, Medicine.

Spontaneous clearance of hepatitis C virus in an interleukin 28B favorable genotype highly prevalent area

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Hepatology.

The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2017 .

Tenofovir versus Entecavir in Treatment of Chronic Hepatitis B Virus with Severe Acute Exacerbation

Sheng-Nan Lu, Chien-Hung Chen, C.-H. Chen, 2015, Antimicrobial Agents and Chemotherapy.

A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, The Journal of antimicrobial chemotherapy.

Combination therapy with interferon‐α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Journal of gastroenterology and hepatology.

Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam

Yueh-Wei Liu, Jing-Houng Wang, Chao-Hung Hung, 2022, Viruses.

Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy.

Chuan‐Mo Lee, Chao-Hung Hung, Shun-Chen Huang, 2007, Journal of the Formosan Medical Association = Taiwan yi zhi.

Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Journal of hepatology.

Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues.

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2014, World journal of gastroenterology.

Characteristics of adefovir resistance in patients with or without lamivudine‐resistant hepatitis B virus treated with adefovir: a 4‐year experience

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Community-Based Mass Ultrasonographic Screening of Hepatocellular Carcinoma among Thrombocytopenic Adults

T. Chen, Sheng-Nan Lu, Chien-Hung Chen, 2008, Cancer Epidemiology Biomarkers & Prevention.

Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.

Chien-Te Lee, Chao-Hung Hung, T. Hu, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of hepatology.

Clinical implications of alpha-fetoprotein in chronic hepatitis C.

Sheng-Nan Lu, Chao-Hung Hung, Wei-Chen Tai, 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2004, Journal of Hepatology.

Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2014, Hepatology International.

Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non‐seroconverted patients during lamivudine therapy

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2007, Liver international : official journal of the International Association for the Study of the Liver.

CASE REPORT: Lamivudine Treatment for Recurrent Pancreatitis Associated with Reactivation of Chronic B Hepatitis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002, Digestive Diseases and Sciences.

Virological Response and Incidence of Adefovir Resistance in Lamivudine-Resistant Patients Treated with Adefovir Dipivoxil

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Antiviral therapy.

The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up

Chao-Hung Hung, T. Hu, Kuo-Chin Chang, 2012, Hepatology International.

Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Journal of hepatology.

HBV relapse rates in patients who discontinue tenofovir disoproxil fumarate with or without switching to tenofovir alafenamide.

Sheng-Nan Lu, Chien-Hung Chen, R. Chien, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical significance and evolution of core promoter and precore mutations in HBeAg‐positive patients with HBV genotype B and C: a longitudinal study

Sheng-Nan Lu, Chao-Hung Hung, Sheng-Nan Lu, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening.

Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2014, PloS one.

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Vaccine.

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2016, International journal of cancer.

Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, Antiviral research.

The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2014, Journal of hepatology.

Title : The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment Short title : HBsAg quantification predicting HBsAg loss

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2014 .

Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis

Meng-Hung Lin, Chao-Hung Hung, Y. Hsieh, 2023, Viruses.

Sustained HCV Clearance by Interferon-Based Therapy Reduces Hepatocellular Carcinoma in Hepatitis B and C Dually-Infected Patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, Antiviral therapy.

Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.

Sheng-Nan Lu, Chien-Hung Chen, R. Chien, 2014, Journal of hepatology.

Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation

Sheng-Nan Lu, Chien-Hung Chen, Chao-Hung Hung, 2019, Digestive Diseases and Sciences.

Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

Sheng-Nan Lu, Chien-Hung Chen, C.-H. Chen, 2017, Scientific Reports.

Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection

C. Lu, Kuan-Der Lee, Chao-Hung Hung, 2021, Biomedical journal.

Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, Hepatology International.

Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, Hepatology International.

Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Acquirement and disappearance of HBsAg and anti‐HCV in an aged population: a follow‐up study in an endemic township

Kow-Tong Chen, Sheng-Nan Lu, Chien-Hung Chen, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis C core antigen highly correlated to HCV RNA

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2018, The Kaohsiung journal of medical sciences.

Did AFP‐L3 save ultrasonography in community screening?

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2018, The Kaohsiung journal of medical sciences.

Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Combining age and HBsAg level predicts post‐treatment durability of nucleos(t)ide analogue‐induced HBeAg seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2015, Journal of gastroenterology and hepatology.

PANCREAS, BILIARY TRACT, AND LIVER Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2015 .

Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications

Sheng-Nan Lu, Chuan‐Mo Lee, Chao-Hung Hung, 2011, Expert review of anti-infective therapy.

Community-Based Screening for Hepatitis B and C Infectivity Using Two Quantitative Antigens to Identify Endemic Townships

Sheng-Nan Lu, Chao-Hung Hung, K. Kee, 2022, Viruses.

Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Digestive Diseases and Sciences.

Antiviral therapy after non‐surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2005, Journal of gastroenterology and hepatology.

A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy.

Sheng-Nan Lu, Chien-Hung Chen, M. Yen, 2012, The Journal of antimicrobial chemotherapy.

Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2009 .

Three‐year efficacy and safety of tenofovir in nucleos(t)ide analog‐naïve and nucleos(t)ide analog‐experienced chronic hepatitis B patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of gastroenterology and hepatology.

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, PloS one.

Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Hepatology International.

Mucinous cystadenoma of the spleen Report of a rare case

C. Changchien, Chao-Hung Hung, S. Chiou, 2000 .

Liver Interleukin-8 Messenger RNA Expression and Interferon Sensitivity-Determining Region Mutations Relate to Treatment Response in Hepatitis C 1B

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Antiviral therapy.

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Chi-Chih Wang, Jing-Houng Wang, Chao-Hung Hung, 2022, Cancers.

Retraction Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target

Chien-Hung Chen, Y. Chiu, Chao-Hung Hung, 2021 .

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

Chien-Hung Chen, Y. Chiu, Chao-Hung Hung, 2014, BioMed research international.

Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study.

M. Kudo, N. Izumi, Yoon-Koo Kang, 2015, Journal of hepatology.

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy

Sheng-Nan Lu, Chien-Hung Chen, Chi-Chih Wang, 2019, Journal of clinical medicine.

Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation

Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang, 2018, Scientific Reports.

Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study

Sheng-Nan Lu, Chien-Hung Chen, Chi-Chih Wang, 2016, Digestive Diseases and Sciences.

The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2014, The Kaohsiung journal of medical sciences.

Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: A follow‐up study of an elderly cohort

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2015, The Kaohsiung journal of medical sciences.

Community‐based cross‐sectional study: The association of lipids with hepatitis C seropositivity and diabetes mellitus

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2012, Journal of gastroenterology and hepatology.

Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2023, AntiCancer Research.

Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Journal of the Formosan Medical Association = Taiwan yi zhi.

Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients

Sheng-Nan Lu, Chien-Hung Chen, M. Tai, 2008, Journal of surgical oncology.

Pangenotypic direct‐acting antiviral agents for mixed genotype hepatitis C infection: A real‐world effectiveness analysis

Sheng-Nan Lu, Chao-Hung Hung, Y. Hsieh, 2021, Journal of gastroenterology and hepatology.

Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection:a multicenter pooled analysis in Taiwan.

Sheng-Nan Lu, Chien-Hung Chen, Chao-Hung Hung, 2020, Journal of viral hepatitis.

Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.

Significance of Vitamin D Receptor Gene Polymorphisms for Risk of Hepatocellular Carcinoma in Chronic Hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2014, Translational oncology.

Natural course of hepatic focal nodular hyperplasia: A long‐term follow‐up study with sonography

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2009, Journal of clinical ultrasound : JCU.

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2003, Journal of gastroenterology.

2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations.

J. Kao, Chun-Jen Liu, Han‐Chieh Lin, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2018, Liver international : official journal of the International Association for the Study of the Liver.

MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2016, Scientific Reports.

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, World journal of gastroenterology.

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2023, Diagnostics.

Favorable α‐fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, Journal of gastroenterology and hepatology.

The incidence of resistance-associated variants to NS5A in HCV subtypes 1a and 1b in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Biomedical journal.

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population.

J. Kao, Chun-Jen Liu, Han‐Chieh Lin, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir

Sheng-Nan Lu, I. Sheen, C.-H. Chen, 2022, Viruses.

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment

Sheng-Nan Lu, I. Sheen, C.-H. Chen, 2020, PloS one.

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Hepatology International.

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, The American journal of gastroenterology.

Neither Diabetes Mellitus nor Overweight Is a Risk Factor for Hepatocellular Carcinoma in a Dual HBV and HCV Endemic Area: Community Cross-Sectional and Case–Control Studies

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, The American Journal of Gastroenterology.

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.

Sheng-Nan Lu, Chien-Hung Chen, Chao-Long Chen, 2010, European journal of cancer.

Sheng-Nan Lu, I. Sheen, C.-H. Chen, 2019, Scientific Reports.

Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2014, Disease markers.

Changing aetiology of liver dysfunction in the new generation of a hepatitis B and C‐endemic area: cross‐sectional studies on adolescents born in the first 10 years after universal hepatitis B vaccination

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2008, Liver international : official journal of the International Association for the Study of the Liver.

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Journal of viral hepatitis.

Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2017, Oncotarget.

Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2011, PloS one.

Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral

Chien-Hung Chen, S. Chiu, Jing-Houng Wang, 2022, Viruses.

Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective study.

Sheng-Nan Lu, C.-H. Chen, Jing-Houng Wang, 2020, American journal of cancer research.

Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patients

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Hepatology International.

Stratification of hepatocellular carcinoma risk through modified FIB‐4 index in chronic hepatitis B patients on entecavir therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Journal of gastroenterology and hepatology.

Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Journal of gastroenterology and hepatology.

The characteristics of patients with macrovascular invasion in hepatocellular carcinoma: when East meets West

Sheng-Nan Lu, Chi-Chih Wang, Yu-Fan Cheng, 2021, Langenbeck's Archives of Surgery.

Amino Acid Substitutions in the Core Region Associate with Insulin Resistance in Chronic Hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Intervirology.

Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection

Chi-Chih Wang, Yueh-Wei Liu, Chao-Hung Hung, 2020, Scientific Reports.

Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C.

C.-H. Chen, S. Chuah, Chao-Hung Hung, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, PloS one.

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2010, The Journal of infectious diseases.

[610] AN OPEN-LABEL, COMPARATIVE, MULTICENTER STUDY OF PEGINTERFERON a-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C/HEPATITIS B CO-INFECTION VERSUS CHRONIC HEPATITIS C MONOINFECTION: AN INTERIM REPORT

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2007 .

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, PloS one.

The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2018, Investigational New Drugs.

Endemic hepatitis B and C virus areas are associated with lower prevalence of hyperlipidemia: Ecological and cross‐sectional studies

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2017 .

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2015, Journal of gastroenterology and hepatology.

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2017, Journal of gastroenterology and hepatology.

Ultrasonographic Quantification of Hepatic–Renal Echogenicity Difference in Hepatic Steatosis Diagnosis

Sheng-Nan Lu, Chao-Hung Hung, Hock-Liew Eng, 2013, Digestive Diseases and Sciences.

Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, BMC Gastroenterology.

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

C.-H. Chen, Chi-Chih Wang, Yueh-Wei Liu, 2020, Scientific Reports.

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, PloS one.

Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2013, The American Journal of Gastroenterology.

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2017, PloS one.

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Investigational New Drugs.

Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, Journal of the Formosan Medical Association = Taiwan yi zhi.

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma

Chi-Chih Wang, C. Yong, Yu-Fan Cheng, 2021, Hepatobiliary surgery and nutrition.

Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy

Sheng-Nan Lu, Chao-Hung Hung, Y. Hsieh, 2023, Diagnostics.

The Efficacy and Safety of Ramucirumab in Heavily Pretreated Advanced Hepatocellular Carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2023, AntiCancer Research.

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

Chien-Hung Chen, Y. Tsai, Chi-Chih Wang, 2020, Scientific Reports.

The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection

Chi-Chih Wang, Chao-Hung Hung, T. Hu, 2019, World Journal of Surgery.

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment

Sheng-Nan Lu, Chien-Hung Chen, Yu-Fan Cheng, 2015, PloS one.

Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high‐risk for hepatocellular carcinoma

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Cancer.

Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.

Sheng-Nan Lu, Chi-Chih Wang, Yueh-Wei Liu, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study

Chien-Hung Chen, Chao-Hung Hung, T. Hu, 2016, PloS one.

Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.

Sheng-Nan Lu, Chien-Hung Chen, Chi-Chih Wang, 2022, Surgical oncology.

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B.

Sheng-Nan Lu, C.-H. Chen, Jing-Houng Wang, 2023, Alimentary pharmacology & therapeutics.

The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, The Journal of infectious diseases.

Liver stiffness‐based score at sustained virologic response predicts liver‐related complications after eradication of hepatitis C virus

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, The Kaohsiung journal of medical sciences.

Liver stiffness‐based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2013, The Kaohsiung journal of medical sciences.

Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Hepatology international.

Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Journal of gastroenterology and hepatology.

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

Community‐based screening for hepatocellular carcinoma in elderly residents in a hepatitis B‐ and C‐endemic area

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2011, Journal of gastroenterology and hepatology.

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Scientific Reports.

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Impact of Steatosis on Long-Term Histological Outcome in Chronic Hepatitis C after Antiviral Therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2005, Antiviral therapy.

Impact of sofosbuvir-based direct-acting antivirals on renal function in chronic hepatitis C patients with impaired renal function: a large cohort study from the nationwide HCV Registry Program (TACR).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution.

J. Kao, Jyh-Jou Chen, Yi‐Hsiang Huang, 2019, The Journal of infectious diseases.

Small hepatic nodules (≤2 cm) in cirrhosis patients: characterization with contrast‐enhanced ultrasonography

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2016, PloS one.

Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Viruses.

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, Open forum infectious diseases.

Hepatocellular carcinoma detected by regular surveillance: Does timely confirmation of diagnosis matter?

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: A surveillance study

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2011, The Kaohsiung journal of medical sciences.

On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Cancers.

Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin.

Sheng-Nan Lu, Chao-Hung Hung, Kuo-Liang Wei, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Flash‐echo gray‐scale imaging in the subtraction mode for assessing perfusion of small hepatocellular carcinoma

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2003, Journal of clinical ultrasound : JCU.

Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Hepatology international.

Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Hepatic steatosis with hepatitis B virus/hepatitis C virus dual infection

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, Hepatology.

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

A. Gasbarrini, W. Li, H. Harputluoglu, 2023, The Lancet.

Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma

Chein-Hui Hung, J. Lung, Chao-Hung Hung, 2014, British Journal of Cancer.

Efficacy and safety of switching to tenofovir alafenamide for chronic hepatitis B patients with advanced fibrosis and partial virologic response to oral nucleos(t)ide analogues (ESTAB-AFPVR) - an interim report

Chien-Hung Chen, Jyh-Jou Chen, Ming‐Lung Yu, 2020, Journal of Hepatology.

Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Case Reports in Oncology.

Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan

Sheng-Nan Lu, Chao-Hung Hung, Y. Hsieh, 2021, BMC Gastroenterology.

Seven centimeters as an optimal cutoff value for prognosis stratification in large monofocal hepatocellular carcinoma

Chi-Chih Wang, Yueh-Wei Liu, Chao-Hung Hung, 2023, Langenbeck's Archives of Surgery.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2008, Liver international : official journal of the International Association for the Study of the Liver.

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, International journal of cancer.

Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment

Chien-Hung Chen, Chao-Hung Hung, Yi-Sheng Liu, 2018, Liver Cancer.

Characteristics of adefovir resistance in patients with or without lamivudine‐resistant hepatitis B virus treated with adefovir: a 4‐year experience

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Liver international : official journal of the International Association for the Study of the Liver.

A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2017, Clinical and Translational Gastroenterology.

Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, The Journal of antimicrobial chemotherapy.

Community‐based screening for hepatocellular carcinoma in elderly residents in a hepatitis B‐ and C‐endemic area

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2011, Journal of gastroenterology and hepatology.

Favorable α‐fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, Journal of gastroenterology and hepatology.

Natural course of hepatic focal nodular hyperplasia: A long‐term follow‐up study with sonography

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2009, Journal of clinical ultrasound : JCU.

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2023, BMC Cancer.